HHMI
CLVS

Howard Hughes Medical Institute’s Clovis Oncology, Inc. CLVS Stock Holding History

Howard Hughes Medical Institute’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-1,259
Closed -$44K – 196
2015
Q4 		$44K Buy
+1,259
New +$81.2K 0.01% 151

Other funds holding CLVS

PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 17.47% 1-Year Est. Return

Howard Hughes Medical Institute's CLVS Position: Q1 2016 in Review

Howard Hughes Medical Institute sold out of Clovis Oncology, Inc. (CLVS) in Q1 2016, closing a stake of 1,259 shares — an estimated $44K sold.

Howard Hughes Medical Institute first reported a position in CLVS in Q4 2015 and held it in 1 quarter. The position peaked at $44K in Q4 2015. 135 funds tracked by Wall St. Rank hold CLVS as of Q1 2016.

  • Howard Hughes Medical Institute reported no remaining Clovis Oncology, Inc. position as of Q1 2016 after selling out during the quarter.
  • Howard Hughes Medical Institute sold 1,259 Clovis Oncology, Inc. shares in Q1 2016, an estimated $44K.
  • Howard Hughes Medical Institute first reported a position in Clovis Oncology, Inc. in Q4 2015 and held it in 1 quarter.
  • Howard Hughes Medical Institute's Clovis Oncology, Inc. position peaked at $44K in Q4 2015.
  • 135 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q1 2016.

Based on Howard Hughes Medical Institute's 13F filing for Q1 2016, filed 10 May 2016.